Showing results (301-310 of 355) with videos related to
Sort By:
Pageof 36
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirusElizabeth K Day, Andrew J Carmichael, Ineke J M ten Berge, et al.European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancerM Gore, A Oza, G Rustin, et al.Blood|July 19, 2003
Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantationMaher K Gandhi, Mark R Wills, Georgina Okecha, et al.Cancer Chemotherapy and Pharmacology|February 22, 2002
A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalationD Fyfe, F Raynaud, R E Langley, et al.Cancer Chemotherapy and Pharmacology|May 11, 2001
A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day scheduleD Fyfe, C Price, R E Langley, et al.Catheterization and Cardiovascular Diagnosis|January 1, 1986
Coronary angioplasty at the time of initial cardiac catheterizationR L Feldman, R G Macdonald, J A Hill, et al.Journal of Experimental Botany|March 7, 2021
Aquaporins, and not changes in root structure, provide new insights into physiological responses to drought, flooding, and salinityJean-Christophe Domec, John S King, Mary J Carmichael, et al.Nature|June 5, 2019
To catch and reverse a quantum jump mid-flightZ K Minev, S O Mundhada, S Shankar, et al.Journal of the National Cancer Institute|November 17, 1993
Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I CommitteeP A Philip, D Rea, P Thavasu, et al.Cancer Research|December 1, 1993
A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopyP A Philip, C H Thompson, J Carmichael, et al.Pageof 36